Philips Boosts Cancer Imaging with Rembra FDA Clearance
Amsterdam, Netherlands – April 22, 2026 In a significant advancement for medical imaging technology, Philips has received U.S. FDA...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Amsterdam, Netherlands – April 22, 2026 In a significant advancement for medical imaging technology, Philips has received U.S. FDA...
AMSTERDAM, Netherlands, April 16, 2026 Royal Philips has announced a major advancement in medical imaging with the U.S. FDA...
